NCR Voyix Corp
For the period ended Dec 31, 2024. Filed Feb 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 27, 2025
VYX$10.03+1.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
| For the years ended December 31 (in millions) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Operating activities | |||
| Net income (loss) | $957 | $(423) | $59 |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |||
| Loss (gain) on debt extinguishment | (8) | 46 | — |
| Depreciation and amortization | 297 | 559 | 610 |
| Stock-based compensation expense | 47 | 177 | 125 |
| Deferred income taxes | 43 | 140 | 60 |
| Loss (gain) on disposal of property, plant and equipment and other assets | — | (2) | (10) |
| Loss (gain) on divestiture | (1,544) | 12 | 9 |
| Impairment of other assets | 11 | 8 | — |
| Gain on terminated interest rate derivative agreements | — | (103) | — |
| Changes in assets and liabilities, net of effects of business acquired: | |||
| Receivables | (57) | 47 | (216) |
| Inventories | 39 | 9 | (188) |
| Current payables and accrued expenses | (115) | 108 | 29 |
| Contract liabilities | 67 | (24) | (1) |
| Employee benefit plans | (38) | (6) | (61) |
| Other assets and liabilities | 169 | 146 | 11 |
| Net cash provided by (used in) operating activities | $(132) | $694 | $427 |
| Investing activities | |||
| Expenditures for property, plant and equipment | $(30) | $(130) | $(92) |
| Proceeds from sale of property, plant and equipment and other assets | — | 8 | 10 |
| Additions to capitalized software | (187) | (247) | (285) |
| Business acquisitions, net of cash acquired | — | (7) | (13) |
| Proceeds from divestiture, net | 2,458 | 96 | (2) |
| Purchases of investments | — | (10) | — |
| Proceeds from disposition of corporate-owned life insurance policies | 36 | — | — |
| Termination of trade receivable facility | (300) | — | — |
| Collections on purchased trade receivables | 212 | — | — |
| Other investing activities, net | — | — | (5) |
| Net cash provided by (used in) investing activities | $2,189 | $(290) | $(387) |
| Financing activities | |||
| Short term borrowings, net | $— | $— | $1 |
| Payments on term credit facilities | (200) | (1,878) | (63) |
| Borrowings on term credit facilities | — | 200 | — |
| Payments on revolving credit facilities | (699) | (2,855) | (1,192) |
| Borrowings on revolving credit facilities | 600 | 2,430 | 1,333 |
| Payments of senior unsecured notes | (1,177) | (1,000) | — |
| Proceeds from issuance of senior unsecured notes | — | — | 12 |
| Payments on other financing arrangements | — | (2) | — |
| Debt issuance costs and bridge commitment fees | — | (5) | — |
| Call premium on debt extinguishment | — | (24) | — |
| Cash dividend paid for Series A preferred share dividends | (15) | (15) | (15) |
| Repurchases of common stock | (56) | — | — |
| Tax withholding payments on behalf of employees | (12) | (34) | (59) |
| Proceeds from employee stock plans | 13 | 27 | 31 |
| Net change in client funds obligations | — | — | (28) |
| Principal payments for finance lease obligations | (14) | (15) | (15) |
| Proceeds from long-term debt related to debt transferred to NCR Atleos at separation | — | 3,016 | — |
| Cash transferred to NCR Atleos at separation | — | (684) | — |
| Other financing activities | — | — | (4) |
| Net cash provided by (used in) financing activities | $(1,560) | $(839) | $1 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | (24) | (20) | (50) |
| Increase (decrease) in cash, cash equivalents and restricted cash | 473 | (455) | (9) |
| Cash, cash equivalents and restricted cash at beginning of period | 285 | 740 | 749 |
| Cash, cash equivalents and restricted cash at end of period | $758 | $285 | $740 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.